SG Americas Securities
MIST icon

SG Americas Securities’s Milestone Pharmaceuticals MIST Stock Holding History

SG Americas Securities’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61K Buy
45,574
+3,062
+7% +$4.89K ﹤0.01% 3186
2026
Q1 		$51K Sell
42,512
-54,863
-56% -$96.1K ﹤0.01% 3023
2025
Q4 		$197K Buy
+97,375
New +$210K ﹤0.01% 2934

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

SG Americas Securities's MIST Position: Q2 2026 in Review

SG Americas Securities increased its Milestone Pharmaceuticals (MIST) stake by 7.2% in Q2 2026, buying an estimated $4.89K and bringing the position to 45,574 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #3186.

SG Americas Securities first reported a position in MIST in Q4 2025 and has held it in 3 quarters since. The position peaked at $197K in Q4 2025. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • SG Americas Securities held 45,574 shares of Milestone Pharmaceuticals worth $61K as of Q2 2026.
  • SG Americas Securities bought 3,062 Milestone Pharmaceuticals shares in Q2 2026, an estimated $4.89K.
  • Milestone Pharmaceuticals made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3186 holding.
  • SG Americas Securities first reported a position in Milestone Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • SG Americas Securities's Milestone Pharmaceuticals position peaked at $197K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.